Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Mr. Adil el Housseini | Cellular Neuroscience | Best Researcher Award

Mr. Adil el Housseini | Ibn Zohr University Agadir Morocco | Morocco

Adil EL Housseini is a dedicated PhD candidate in biology at Ibn Zohr University, Faculty of Sciences of Agadir, specializing in toxicology, biochemistry, and the molecular characterization of scorpion venoms. His doctoral research explores the biochemical composition, ecotoxicity, and pathophysiological mechanisms of venoms from selected Buthid species, with a particular focus on developing novel therapeutic strategies for scorpion envenomation. Adil has contributed to the scientific community through peer-reviewed publications and authored book chapters spanning biomedical polymers, chitosan-based therapeutic applications, radioprotective biomaterials, and neurobiological insights into astrocyte function. His work on the kinetics of brain oxidative stress following scorpion envenomation highlights his strong command of experimental toxicology and neurobiochemical analysis. With an h-index of 1, two indexed documents, and two citations, he continues to build a research profile grounded in rigorous experimentation and interdisciplinary scientific inquiry. Adil’s skills include venom biochemistry, laboratory toxicology, data interpretation, and scientific writing, supported by strong language proficiency in Arabic, French, and English. His commitment to advancing knowledge in venom toxicology and biomedical sciences positions him as a promising emerging researcher contributing to both fundamental understanding and applied therapeutic innovation.

Profile: Google Scholar | Orcid

Featured Publications

Ait Hamdan, Y., Rhazi, M., El-Mansoury, B., Kabdy, H., Oukhrib, M., Ait Baba, A., … (2024). Astrocytes functions and their involvement in brain injury: A focus on the biomaterials’ role in mitigating traumatic brain injury. In Physiology and Function of Glial Cells in Health and Disease (pp. 145–163).

Mabsor-Zgandaoui, S., Rachmoune, K., Aftais, I., Elamrani, F. E., Amradi, I., … (2026). Biomedical polymers: Foundations and future innovations in medicine. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Ait Hamdan, Y., Armadi, I., Elamrani, F. E., Mekouar, M., El Housseini, A., … (2026). Therapeutic implications of chitosan and its derivatives: Focus on cancer treatment. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Rachmoune, K., Mabsor-Zgandaoui, S., El Housseini, A., Ait Hamdan, Y., … (2026). Radioprotective effects of chitosan polysaccharides and biomedical applications. In Biomedical Applications and Toxicity of Polymers, Nanoparticles

Armadi, I., Elouali, S., Abana, A., El Housseini, A., Loqman, S., & Belbachir, A. (2025). Overview of biomaterials classification, properties, and biomedical applications. In Innovations and Applications of Advanced Biomaterials in Healthcare 

Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Dr. Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Dr. Hui Gan | Chongqing Medical University | China

Professor Hui Gan is a distinguished researcher at Chongqing Medical University, serving as a master’s supervisor, associate research fellow, and Assistant to the Dean of the School of Basic Medical Sciences, where she also leads the Department of Pathophysiology in an acting capacity. Her research primarily focuses on neuroinflammation, microglial regulation, and inflammasome-mediated injury following cerebral hemorrhage, with significant contributions to understanding TRIM21-mediated mechanisms and microglial transcriptional pathways such as c-MAF–NLRP3 signaling. She has secured multiple competitive national and regional research grants supporting investigations into inflammasome activation, microcirculatory dysfunction, and post-hemorrhagic inflammatory injury. Professor Gan has received notable recognitions, including awards for early-career excellence and contributions to microcirculation research. She plays an active role in professional societies as a committee member of the Microcirculation Committee of the Chinese Society of Pathophysiology and a young committee member of the Translational Medicine Committee of the Chinese Society of Microcirculation, contributing to academic development in basic and translational medical sciences. Her scholarly output includes 18 documents, with 196 citations across 175 citing documents, reflecting a solid research impact supported by an h-index of 8. Through her scientific leadership and innovative research, she continues to advance understanding of inflammatory mechanisms in neurological injury.

Profile: Scopus

Featured Publication

Gan, H., Gan, H.-Y., Zhang, M., Duan, Y., Palahati, A., He, Q., Tan, J., Li, Y., Zhai, X., & Zhao, J. (2025). Microglial NFAT5 aggravates neuroinflammation via mediating NLRP6 inflammasome in experimental ischemic stroke. Genes and Diseases, 12(6),

Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Wagdy Khalil |  National Research Centre | Egypt

Dr. Wagdy Khalil is a Professor of Animal Genetics specializing in Molecular Genetics at the Cell Biology Department, National Research Centre, Egypt. His research focuses on genetic and molecular mechanisms underlying animal reproduction, gene expression, and environmental genotoxicity. He has significantly contributed to the understanding of oocyte maturation, preovulatory hormonal regulation, and molecular responses to toxins, nanoparticles, and natural therapeutic agents. Dr. Khalil’s work integrates molecular biology, biotechnology, and animal genetics to explore the genetic basis of fertility, mutagenicity, and disease resistance. He has published 161 scientific papers in peer-reviewed journals indexed in Scopus, reflecting his consistent research productivity and international collaboration. His studies have advanced knowledge in fields such as reproductive biology, toxicogenomics, molecular diagnostics, and genetic engineering. Dr. Khalil’s impactful research has earned him 2,055 citations from 1,801 documents, demonstrating wide recognition within the scientific community. With an h-index of 27, his work continues to influence emerging research in molecular genetics and biotechnology, bridging fundamental discoveries with applied biomedical and agricultural innovations.

Featured Publications

  • Antiarthritic activities of berberine in a rat model of gouty arthritis. (2025). Scientific Reports.

  • Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. (2025). Scientific Reports.

  • Comparative study of pyridine and pyrimidine derivatives as promising anti-inflammatory agents: Design, synthesis, and LPS-induced RAW 264.7 macrophages. (2025). Drug Development Research.

  • Expression of growth factors in buffalo ovarian tissue across different follicular developmental stages. (2025). Archives of Gynecology and Obstetrics.

  • Estrus, preovulatory LH surge and oocyte maturation in Goettingen miniature pigs (Sus scrofa domesticus). (2025). Theriogenology.

  • Targeting apoptotic pathways in cancer: Design, synthesis, and molecular docking studies of 1,3,5-trisubstituted-1H-pyrazole derivatives with Bcl-2 inhibition and DNA damage potential. (2025). RSC Advances.

  • Assessment of the gold nanoparticles biosynthesized using Casuarina equisetifolia bark extract against the ethion-induced hepato- and neurotoxicity in rats. (2025). Journal of Genetic Engineering and Biotechnology.

  • In vitro and in vivo antidiabetic evaluation of new coumarin and chromone derivatives: Design, synthesis, and molecular modeling. (2025). Bioorganic Chemistry.

  • Potential therapeutic effects of interleukin-1 receptor type 1 antagonist and the ethyl acetate fraction of Murraya exotica leaves against κ-carrageenan-induced vein thrombosis in rats. (2025). Phytomedicine Plus.

  • The ability of stressor factors of environmental pollution to induce ROS and 8-OHdG mediated apoptosis in fish species of Suez Gulf, Red Sea. (2025). Egyptian Journal of Chemistry.

Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song,  Shanxi University of Chinese Medicine, China.

Throughout my career, I have passionately committed myself to integrating traditional Chinese medicine and Western medicine to advance the prevention and treatment of brain diseases, particularly ischemic cerebrovascular diseases and neurodegenerative disorders. By leading 14 national and provincial-level research projects, publishing over 130 academic papers, and contributing significantly to educational reform, I have built a strong foundation of scientific innovation and clinical excellence. With achievements recognized both nationally and internationally, and a consistent focus on combining research, teaching, and clinical work, I have significantly impacted the fields of neuroprotection and integrative medicine.

Profile

Scopus

 

🎓 Early Academic Pursuits

From the outset of my academic journey, I committed myself to the profound study of both traditional Chinese medicine and Western medicine, aspiring to bridge these two disciplines for the betterment of brain disease treatment. I pursued a rigorous path of education and research, laying a strong foundation that later allowed me to integrate diverse medical perspectives. Early in my career, I developed a particular interest in ischemic cerebrovascular diseases and neurodegenerative conditions, setting the stage for my lifelong mission to innovate in these critical areas.

🩺 Professional Endeavors

My professional career has been a dynamic blend of teaching, clinical practice, and scientific research, with a special focus on the prevention and treatment of brain diseases. I have successfully presided over 14 prestigious national and provincial-level projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Through my work, I have consistently emphasized the value of integrating traditional Chinese medicine with modern Western practices, ensuring that my clinical and research contributions are both culturally rooted and globally relevant.

🔬 Contributions and Research Focus

Throughout my research journey, I have concentrated on ischemic cerebrovascular diseases and neurodegenerative diseases, pioneering integrated approaches for their prevention and treatment. I have published 133 scientific papers, including 45 in SCI-indexed journals, with nearly 700 citations and an H-index of 15. One of my papers published in Neural Regeneration Research (NRR) has been recognized in the ESI highest citation list, achieving an impressive 97 citations. Beyond scientific research, I have also contributed significantly to educational innovation, authoring educational reform articles in the China Journal of Traditional Chinese Medicine and editing influential academic books.

🏆 Accolades and Recognition

My dedication to scientific advancement and education has earned me multiple prestigious honors. As the first author, I received the First Prize of the Academic Achievement Award from the China Association for the Promotion of Traditional Chinese Medicine Research. I have secured three authorized patents and two software copyrights, further showcasing my commitment to innovation. Additionally, my work has been featured through oral presentations at internationally renowned academic forums such as the Autoimmunity Congress and the World Stroke Congress, and recognized by respected platforms like Logic Neuroscience and Neuroweekly.

🌍 Impact and Influence

My influence extends beyond academia into public science education and medical philosophy dialogues. I have been repeatedly invited to deliver popular science talks and academic lectures at events like the Medical Philosophy Expert Meeting Room. My presentation at the 2022 International Neural Regeneration Summit Forum earned the Most Popular Award, affirming my ability to translate complex research into impactful and accessible knowledge for diverse audiences.

📚 Legacy in Education and Publishing

In addition to research and clinical achievements, I have made significant contributions to academic publishing and educational reform. My independently authored book, Progress in Integrated Traditional Chinese and Western Medicine Prevention and Treatment of Ischemic Cerebrovascular Disease, was published by People’s Health Publishing House. I have served as the first editor-in-chief for three important books, including Exploration of Teaching Models in Higher Education Pharmaceutical Education, which was honored by its selection into the “Library of Young Scholars in Universities,” marking a lasting contribution to the future of pharmaceutical education.

🚀 Future Contributions and Aspirations

Looking ahead, I aspire to further deepen the integration of traditional Chinese and Western medicine, particularly in brain disease prevention and therapy. I am committed to leading new research directions, fostering international collaborations, and nurturing a new generation of scholars who value the richness of cross-cultural medical practices. My future endeavors will continue to reflect a relentless pursuit of scientific excellence, compassionate clinical practice, and transformative education for the global health community.

Publication

  • Title: Effect of tetramethylpyrazine on neuroinflammation after cerebral ischemia and hypoxia based on mannose-binding lectin
    Authors: Y. Duan, Yanzhe; J. Hua, Jianlin; Y. Yan, Yuqing; L. Song, Lijuan
    Year: 2025

 

  • Title: Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation
    Authors: J. Yu, Jiezhong; C. Ma, Cungen
    Year: 2025

 

  • Title: Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop
    Authors: L. Song, Lijuan; Y. Wu, Yige; L. Yin, Lijun; B. Xiao, Baoguo; C. Ma, Cungen
    Year: 2025

 

  • Title: Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell
    Authors: B. Mu, Bingtao; M. Guo, Minfang; J. Yu, Jingwen; J. Yu, Jiezhong; L. Song, Lijuan
    Year: 2025

 

  • Title: Effectiveness and Safety of Blending Traditional Chinese Medicine With Western Medicine for Enhanced Secondary Stroke Prevention: A Meta-analysis of RCTs
    Authors: C. Wen, Chunli; L. Song, Lijuan; C. Ma, Cungen; F. Hu, Fengyun; L. Zhu, Linggqun
    Year: 2025

 

 

🎯 Conclusion

Driven by a deep belief in the power of integration between ancient wisdom and modern science, I have continuously sought to pioneer new frontiers in brain disease treatment. My work has not only advanced research but also nurtured future generations through educational contributions and public science communication. Moving forward, I remain committed to expanding the reach and depth of integrated medicine, aiming to create a lasting legacy of innovation, healing, and academic excellence for global healthcare advancement.